Mycoplasma hyopneumoniae remains an important pathogen in swine industry. The aim of the present work was to assess M. hyopneumoniae vaccine from viewpoint of antibodies formation, health, daily weight gain, quality of meat and lung lesions. The investigation was carried out on forty four cross-bred 7-day-old piglets free from M. hyopneumoniae infection. Twenty two piglets were vaccinated intramuscularly. The other group of twenty two piglets was used as a control (unvaccinated). The results showed that in both groups the antibodies against Mycoplasma hyopneumoniae were not formed before vaccination. Antibodies against enzootic pneumonia in the vaccinated group were formed after fourteen days from the second vaccination and remained present until day 77. It was observed that in unvaccinated group antibodies against M. hyopneumoniae had not been formed. Pigs with artificially acquired active immunity from vaccination achieved higher daily weight gain, growth rate, fattening and finishing weight, improved quality of meat and decreased pneumonia lesions than the pigs in the control group.
U.S.A.) of 2 ml behind the ear, as recommended by vaccine protocol. The first dose was administered during the first week of life. After 14 days the second vaccination followed at the same vaccine doses. The other group of 22 piglets (11 males and 11 females at the age of 7 days) was used as control (unvaccinated) group. Blood samples of both groups of piglets were taken before vaccination and on days 21, 35, 49, 63, 77 after vaccination.
Concentration of M. hyopneumoniae specific antibodies in serum was determined by blocking ELISA (Dako, Denmark). The serum samples were diluted 1:10 and incubated for 1 1 /2 h in microwells precoated with M. hyopneumoniae antigen. Then without emptying the wells, peroxidase-conjugated mouse monoclonal antibody to a M. hyopneumoniae -specific epitope on 74 kDa protein was added. The higher the antibody concentration in a pig serum was, the less monoclonal antibody conjugate was bound to the well. After 15 min of incubation the microwells were washed and chromogenic substrate (1.2 phenylenediamine dihydrochloride) was added. A golden-brown colour developed in all wells, and after 10 min the reaction was stopped by the addition of sulphuric acid. The higher the antibody concentration in the pig serum specimen was, the lower the intensity of the colour was detected in the well. The absorbance (OD) in each microwell was read at 490 nm and the absorbance of specimen wells was compared with the absorbancy of a buffer control well. Positive specimens gave OD -values, which were less than 50 of the OD -value of the buffer control well.
The vaccinated and control animals were housed separately during the weaning and thereafter. During the fattening period they were kept in the same air space but were separated by a door. At the age of 33 days the piglets were transferred to the post-weaning unit. They were weighed individually at each move between units and subsequently to slaughter.
Prevention measures (castration, iron injection, needle teeth clipping, tail docking) and other management practices were identical for both groups.
Vaccinated and control groups were compared during weaning/growing/ finishing period. Live body weight was measured at the age of 7, 33, 107 and 206 days. Daily weight gain (DWG) in each group was calculated as the difference between mean weight at the start and at the end of finishing period divided by the number of fattening days of a group.
Back fat thickness, muscle thickness and lean meat content were recorded by ultrasound PIGLOG 105 measurement (SFK -Technology, Denmark) before slaughter. The measurement was performed at two predetermined anatomical sites: fat 1 between 3 rd and 4 th last lumbar vertebrae (7 cm from midline) fat 2 and muscle thickness between 3 rd and 4 th last rib (10 cm) and 7 cm from midline.
The lungs of vaccinated and unvaccinated groups of pigs were examined at slaughter. The same person determined the incidence of macroscopic lesions. Lung lesion was scored by percentage (Goodwin et al. 1968 ). The extent of lung lesions was recorded onto a lung diagram. Surface areas showing pneumonia for each lobe were given a score from 1 to 5. Total score by per cent is 55. This consist from left apical lobe10%, right apical lobe 10%, left cardiac lobe 10%, right cardiac lobe 10%, cranial edge of left diaphragmatic lobe 5%, cranial edge of right diaphragmatic lobe 5% and for intermediate lobe 5%. The lung lesions were also evaluated by score method. The maximum score for each lobe was 5 and for the all lungs 35 (Hannan et al. 1984) .
Percentage of reduction in lung lesion scores relative to control group was calculated for the vaccinated group by formula -mean control group minus vaccinated group multiply by 100 and divided to mean control group.
Lungs with gross lesions were selected for microbiology investigations. All mycoplasma cultivation procedures were performed according to the methods used by the Mycoplasma Section at the Danish Veterinary Laboratory, Copenhagen (F riis 1974, 1975) . For mycoplasma isolation, tissue was homogenized in tissue grinder using 5 ml of Friis medium. Lungs suspensions were inoculated in 10 -100 000 fold dilutions in Friis medium. Inoculation was carried out at +35 -37 °C in a roller drum. Cultures with acid shift were subcultured 3 -5 times and inoculated on Friis agar. Isolated strains of mycoplasma were identified by the disc growth inhibition test (DGI), using antisera against the type "J" strain of M. hyopneumoniae and strain Ms 42 of Mycoplasma flocculare (M. flocculare).
Statistical analyses were performed using Microsoft Excel software. Significance was set at P < 0.05.
Results
The antibodies against M. hyopneumoniae were not detected before immunisation in both groups. The mean OD -value of vaccinated and control groups were 119. 52% and 119.12%, respectively.
Antibodies against M. hyopneumoniae in the vaccinated group had been formed on 14 days after the second vaccination. OD -value of positive pigs in vaccinated and unvaccinated groups was 14.24% and 90.21%, respectively. Concentration of antibodies in vaccinated group remained till 77 days (OD -value 46.6). In control group all sera samples were seronegative -OD -value 128. 48%. Table 1 shows the presence of antibodies against M. hyopneumoniae.
The DWG increased by 28 grams (g) in the vaccinated group compared to that of the control group. The growing body weight of the vaccinated group was significantly greater by 9.55 kg (P < 0.001) than that of control group (Table 2) .
In vaccinated group the measurements of fat 1 and fat 2 were less by 0.82 mm and 1.39 mm, respectively. Muscles in vaccinated group were bigger by 1.55 mm, the percentage of lean meat was larger in vaccinated group (Table 3) .
Significantly larger proportion of lung surface with pneumonic lesions was detected among the unvaccinated pigs. Lower percentage rate of the lungs belonging to the vaccinated pigs had pneumonic lesions, indicating the efficiency of the used vaccine. Evaluation of lung lesions was made using two methods (Table 4) .
M. hyopneumoniae was not isolated from lung specimens collected from vaccinated pigs. However, it was cultured from 5 out of 22 lungs (22.73) of the unvaccinated pigs.
Discussion
A commercial M. hyopneumoniae bacterin induced protection against mycoplasmal pneumonia in pigs (D iekman et al. 1999; Maes et al. 1999; Thacker et al. 2000) . According to the manufacturer guidelines, the piglets received the first dose at about 1 week Table 1 Mycoplasma hyopneumoniae antibodies in pigs aged 7-77 days Table 2 Effect vaccine on some production indices of pigs Table 3 Effect of vaccination on quality of meat of age and the second dose after 2 weeks. Piglets younger than 3 days of age were not vaccinated because it is unclear whether the immune response in the pigs is optimal (Hammerberg et al. 1989 ). In the vaccinated group antibodies were detected 14 days after the second vaccination. In this group concentrations of specific serum antibodies were detectable on day 77. In unvaccinated pig group, M. hyopneumoniae specific antibodies had been not formed and enzootic pneumonia infection occurred. The DWG, one of the most important biological index, showed significant difference (28 g) in vaccinated pigs. The weight gain was lower than that observed (40 g) in field trials with Stellamune Mycoplasma (Charlier et al. 1994) . In our studies the weight of vaccinated pig group increased during growing/fattening/finishing period. Percentage reduction in lung lesions in the vaccinated group reached 66% by Goodwin and 57.4% by Hannnan. M. hyopneumoniae was isolated from lungs specimens collected from unvaccinated pigs (22.73%). Ross et al. (1992) described more extended typical lung lesions (30% to 80%) of slaughter pigs. The lean meat, muscle thickness was greater in vaccinated group.
In conclusion, the results of our study indicate that pigs with artificially acquired active immunity had higher average daily weight gains, improved meat quality and reduced pneumonia lesions than the pigs in the non-vaccinated control group.
Sledování úãinku vakcinace proti Mycoplasma hyopneumoniae u prasat od narození do poráÏky
Mycoplasma hyopneumoniae zÛstává i nadále pro velkochovy prasat závaÏn˘m patogenem. Cílem pfiedkládané práce bylo zhodnotit úãinek vakcinace proti M. hyopneumoniae z hlediska tvorby protilátek, zdraví zvífiat, jejich denních pfiírÛstkÛ na váze, kvality masa a mnoÏství zji‰tûn˘ch plicních lézí. Na‰e sledování byla provádûna ve skupinû ãtyfiiceti ãtyfi 7denních selat -kfiíÏencÛ, prost˘ch infekce M. hyopneumoniae. Intramuskulárnû bylo vakcinováno dvacet dva selat. Zb˘vajících dvacet dva selat slouÏilo jako kontrolní nevakcinovaná skupina. Z dosaÏen˘ch v˘sledkÛ vypl˘vá, Ïe ani v jedné skupinû sledovan˘ch selat nedo‰lo pfied vakcinací k tvorbû protilátek proti M. hyopneumoniae. Specifické protilátky proti enzootické pneumonii prasat byly ve skupinû vakcinovan˘ch selat zji‰tûny za ãtrnáct dnÛ po druhé vakcinaci a pfietrvávaly aÏ do 77. dne po vakcinaci.. Ve skupinû nevakcinovan˘ch selat protilátky proti M. hyopneumoniae detekovány nebyly. Selata s aktivní imunitou, navozenou uvedenou vakcinací, dosahovala vy‰‰ích denních pfiírÛstkÛ na váze, rychlej‰ího rÛstu, vy‰‰í poráÏkové váhy, vy‰‰í kvality masa a niÏ‰ích poãtÛ plicních lézí, ve srovnání se selaty z kontrolní nevakcinované skupiny.
